A New Path Forward: The Therapeutic Potential of Next Generation BTK Inhibitors in CLL/SLL

Access Activity

Overview / Abstract:

Targeted agents such as Bruton tyrosine kinase (BTK) inhibitors dramatically changed the treatment landscape for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Unfortunately, challenges with tolerance and resistance are pervasive with these agents. Novel highly selective, non-covalent (reversible) BTK inhibitors that may overcome these challenges are undergoing investigation in clinical trials and have the potential to significantly enhance the treatment of CLL/SLL. In early clinical trials, these agents improved overall response rates, irrespective of prior therapy or mutation status.

With the high volume of new clinical trial data related to CLL/SLL, the hematology/oncology team may be challenged to incorporate these new practice-altering therapies into current treatment plans. Ensure that your team is ready to introduce these therapies to best meet the needs of their diverse patients with CLL/SLL and engage with a leading oncology expert real-time. Schedule your virtual meeting today!

Expiration

Mar 31, 2023

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Grand Rounds, Online

Credits / Hours

1.0

Accreditation

ACCME

Presenters / Authors / Faculty

Chair
Nitin Jain, MD
Associate Professor
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Co-Chair
Jacqueline Barrientos, MD, MS
Chief, Hematologic Malignancies
Director, Oncology Research
Associate Professor at the Columbia University Division of Hematology/Oncology at Mount Sinai Medical Center
Adjunct Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Adjunct Associate Professor, Feinstein Institutes for Medical Research
Mount Sinai Medical Center
Miami Beach, FL

Faculty
Catherine Coombs, MD
Associate Clinical Professor
Division of Hematology/Oncology, Department of Medicine
UCI Health
Orange, CA

Sameer Parikh, MD, MBBS
Assistant Professor of Medicine
Department of Medicine, Division of Hematology
Mayo Clinic
Rochester, MN

Sponsors / Supporters / Grant Providers

Sponsored by the Academy for Continued Healthcare Learning.
Supported by an educational grant from Lilly.

Keywords / Search Terms

ACHL grand rounds, virtual, Bruton’s tyrosine kinase, BTK inhibitors, chronic lymphocytic leukemia, CLL, small lymphocytic lymphoma, SLL, emerging therapies, hematology, oncology, precision medicine, targeted agents Free CE CME Seminar CE CME

LIVE Activity Location Details

Date(s)
11-30--0001

Various
 

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map